Ketogenic Diet Treatment for Adolescents with Bipolar Disorder
A 16-Week Study Combining Diet and Medication for Mood Improvement
Led by University of California, Los Angeles · Updated on 2026-04-22
80
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the effects of a ketogenic diet combined with standard medication in adolescents and young adults aged 12 to 21 who are experiencing depressive or mixed phases of bipolar disorder. This open trial aims to determine if adding a 16-week ketogenic diet to usual pharmacological treatments is well-tolerated and linked to improvements in depression, inflammation, metabolism, and executive functioning. The study involves 80 youth from four sites, focusing on feasibility, adherence, and potential symptom and health benefits.
Participants follow a strict ketogenic diet for 16 weeks, with weekly coaching from dietitians who help with meal planning and monitor dietary intake, ketone levels, and side effects. The study includes a 4-week intake and assessment phase, a 2-3 week diet ramp-up period where participants gradually increase keto meals, the main 16-week ketogenic therapy phase, and a final post-treatment evaluation week. Youth receive standard psychiatric care throughout, including medication management and side effect monitoring by study psychiatrists.
During the study, participants undergo regular assessments including blood tests for metabolic and inflammatory markers, monthly symptom evaluations, and cognitive testing. They use a blood ketone meter daily to track ketosis, with data shared securely with the study team. Monthly visits with psychiatrists and weekly dietitian sessions support safety and adherence. Outcome measures include diet adherence, symptom changes, metabolic health, and functioning, with the total participation lasting about 23 weeks including all phases.
CONDITIONS
Brief Title
Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents
Research Team
D
David J Miklowitz, Ph.D.
D
Danielle M Denenny, Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Ketogenic Diet (with coaching)
Pharmacological Therapy (Guideline-Directed)
What is it?
A structured ketogenic diet program designed and monitored by dietitians, delivered over 16 weeks to adolescents with active bipolar spectrum disorder symptoms.
Medication-based treatment as recommended by international guidelines, including mood stabilizers, atypical antipsychotics, and adjunctive psychotherapy, tailored to symptom type and severity in adolescents with bipolar disorder.
Role in clinical care or study
All participants receive the ketogenic diet intervention to evaluate its feasibility, tolerability, and impact on mood symptom severity.
Pharmacological and supportive therapies are the primary established treatment and standard of care for adolescents with bipolar disorder in routine clinical settings.
Primary clinical use / study goal
To assess if a ketogenic diet is feasible, tolerable, and can improve mood symptoms in adolescents with bipolar spectrum disorders.
To stabilize mood, treat acute symptoms (mania, hypomania, depression), prevent recurrence, and support psychosocial functioning using approved medications and therapies.
How is it given or performed?
Participants follow an individualized strict ketogenic diet plan at home, adjusted and reviewed during weekly sessions with a dietitian across the 16-week study period.
Medications are prescribed and adjusted by a psychiatrist or physician, often combined with psychological therapies and routine monitoring in outpatient or community settings.
Evidence status
Efficacy for mood symptom improvement in adolescent bipolar disorder remains unestablished; evidence is limited to pilot trials and emerging case reports.
Efficacy of pharmacological agents such as lithium, select atypical antipsychotics, and mood stabilizers for symptom control and relapse prevention is well established in adolescents through randomized trials and systematic guidelines.
Important limitations
Potential challenges with strict dietary adherence and limited evidence for benefit in mood disorders; contraindications for several medical and psychiatric conditions; not currently standard care for pediatric bipolar disorder.
Potential medication side effects, need for regular safety monitoring, incomplete response rates, and residual functional or mood symptoms for some adolescents despite optimal therapy.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 12Years - 21Years
All Genders
Eligibility Criteria
You may qualify if you...
Youth aged 12 to 21 years who speak English
Suitable for outpatient treatment; not acutely psychotic, suicidal, or manic
Diagnosed with bipolar I, II, or other specified bipolar spectrum disorder
Active depressive or mixed symptoms with specific severity ratings
Willing to participate in psychiatric and dietitian visits for evaluation and medication management
For minors, at least one English-speaking parent or guardian must consent and be available
Youth and caregivers willing to try ketogenic therapy and adhere to study protocol
You will not qualify if you...
Pregnancy or breastfeeding
Underweight (BMI below 18.5) or wasting syndrome
Current or past anorexia nervosa or current bulimia/binge eating disorder
Autism spectrum disorder level 2 or higher
History of cardiac issues, arrhythmia, cardiovascular or cerebrovascular disease
Type I or II diabetes
History of seizures or epilepsy
History of stroke or cancer
Unstable respiratory conditions
Severe gastroesophageal reflux disease despite medication
Substance use disorder except mild cannabis or nicotine use
History of kidney stones or disease
Diseases of pancreas, liver, gallbladder, or thyroid
High cholesterol or triglycerides requiring physician review
Current use of certain diabetes or antihypertensive medications (SGLT-2 inhibitors, insulin, sulfonylureas, ACE inhibitors, ARBs, spironolactone, thiazide diuretics)
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Initial phone screen followed by in-person consenting and psychiatric evaluation visits
Ketogenic Preparation and Ramp Up
Duration - 2 to 3 weeks
Participants prepare for the ketogenic diet by gradually introducing keto meals and completing pre-diet assessments including mood, functioning, and neuropsychological testing.
Weekly visits with the dietitian
Ketogenic Therapy
Duration - 16 weeks
Participants follow a strict ketogenic diet for 16 weeks with weekly dietitian coaching and daily self-administered blood ketone and glucose testing to maintain ketosis. Monthly psychiatric visits support medication management and safety monitoring.
Weekly dietitian visits, daily self-testing, and monthly psychiatrist visits
Post-Treatment Assessments
Duration - 1 week
Participants complete post-treatment evaluations including symptom assessments, neuropsychological testing, and psychosocial functioning measures.
1 to 2 visits for final assessments
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Study of Liposomal Mitoxantrone Combination Treatment for Relapsed and Refractory Solid Tumors in Children, Adolescents, and Young Adults Aged 6 to 24
Home-based Brain Stimulation Using tDCS for Adults with Bipolar Depression A Randomized, Placebo-Controlled Study
Validation and Adaptation of the Hypomanic Personality Scale HPS-6 for Romanian Adults Aged 18 to 50
Study Using Multi-Modal Sentiment Analysis to Predict Recurrence Risk in Bipolar Disorder
Observational Study Including Patients and Healthy Controls Aged 18 to 64
Virtual Screening and Brief Intervention for Alcohol and Drug Use
in Adolescents Aged 12 to 17 via Telehealth in Pediatric Primary Care
Study of High-Level Cognitive Impairments in Adults With Various Neuropsychiatric and Neurological Disorders Compared to Healthy Volunteers
Ketogenic Diet Treatment for Adolescents with Bipolar Disorder
A 16-Week Study Combining Diet and Medication for Mood Improvement
Studying Relationship Addiction in Adults Aged 18 to 45 with Borderline Personality Disorder, Bipolar Disorder, or No Psychiatric Disorders
Study of How Long-Term Smartphone Use Affects Neck Posture, Muscle Strength, and Jaw Joint Awareness in Adolescents Aged 17 to 19
Creating a Global Linked Research Resource Combining Genetic Data and Health Records to Improve Diagnosis and Treatment of Serious Mental Illness and Dementia
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.
Eric H Kossoff, Beth A Zupec-Kania, Stéphane Auvin...
Efficacy of Ketogenic Diet, Modified Atkins Diet, and Low Glycemic Index Therapy Diet Among Children With Drug-Resistant Epilepsy: A Randomized Clinical Trial.
Vishal Sondhi, Anuja Agarwala, Ravindra M Pandey...